SG11201705694VA - Chlorophyll composition - Google Patents

Chlorophyll composition

Info

Publication number
SG11201705694VA
SG11201705694VA SG11201705694VA SG11201705694VA SG11201705694VA SG 11201705694V A SG11201705694V A SG 11201705694VA SG 11201705694V A SG11201705694V A SG 11201705694VA SG 11201705694V A SG11201705694V A SG 11201705694VA SG 11201705694V A SG11201705694V A SG 11201705694VA
Authority
SG
Singapore
Prior art keywords
chlorophyll composition
chlorophyll
composition
Prior art date
Application number
SG11201705694VA
Inventor
Chitra Vasant Savangikar
Vasant Anantrao Savangikar
Original Assignee
Chitra Vasant Savangikar
Vasant Anantrao Savangikar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chitra Vasant Savangikar, Vasant Anantrao Savangikar filed Critical Chitra Vasant Savangikar
Publication of SG11201705694VA publication Critical patent/SG11201705694VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11201705694VA 2015-01-19 2016-01-15 Chlorophyll composition SG11201705694VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN178MU2015 2015-01-19
PCT/IN2016/050017 WO2016116950A2 (en) 2015-01-19 2016-01-15 Chlorophyll composition

Publications (1)

Publication Number Publication Date
SG11201705694VA true SG11201705694VA (en) 2017-08-30

Family

ID=56417899

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201705694VA SG11201705694VA (en) 2015-01-19 2016-01-15 Chlorophyll composition

Country Status (10)

Country Link
US (1) US20180325915A1 (en)
EP (1) EP3247323B1 (en)
JP (2) JP6772151B2 (en)
CN (2) CN117100756A (en)
AU (1) AU2016210540B2 (en)
BR (1) BR112017015338A2 (en)
EA (1) EA201791319A1 (en)
ES (1) ES2879996T3 (en)
SG (1) SG11201705694VA (en)
WO (1) WO2016116950A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117100756A (en) * 2015-01-19 2023-11-24 C·V·萨万基卡尔 Chlorophyllin compositions and uses thereof
EP4059493A1 (en) * 2021-03-16 2022-09-21 The Secretary, Department Of Atomic Energy A chlorophyllin containing pharmaceutical composition for prevention of pathogenesis of coronavirus disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729586A (en) * 1952-02-01 1956-01-03 Rystan Company Therapeutic compositions comprising water - soluble chlorophyll and salts of fatty acids
BE516996A (en) * 1952-02-19
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
DE4033530A1 (en) * 1990-10-22 1992-04-23 Univ Schiller Jena Crystallisation inhibitor for treating kidney stone disorders - contains an ethanolic extract of madder contg. 0.2-1.0 per cent ruberythric acid
JPH04327534A (en) * 1991-04-24 1992-11-17 Mitsuo Namiki Agent for preventing and treating disorder of human body caused by active oxygen
JPH04356420A (en) * 1991-05-31 1992-12-10 Nisshin Flour Milling Co Ltd Thiamine-cobalt-chlorophyllin complex compound-containing composition
JP3657203B2 (en) * 2000-04-21 2005-06-08 エーザイ株式会社 Copper chlorophyllin salt-containing liquid composition
JP2003081741A (en) * 2001-09-13 2003-03-19 Nikko Seiyaku Kk Skin care preparation
JP4068442B2 (en) * 2001-12-03 2008-03-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 Taste improving composition
PL1846106T3 (en) * 2005-01-31 2013-03-29 Dong Wha Pharm Co Ltd Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts
WO2007143002A2 (en) * 2006-05-31 2007-12-13 Interhealth Nutraceuticals, Inc. Nutraceutical treatments for diabetic and non-diabetic wound healing
US7947827B2 (en) * 2006-06-30 2011-05-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use
US20080317725A1 (en) * 2007-06-20 2008-12-25 Baum Seth J Compositions and methods of treating chronic kidney disease
JP2009256228A (en) * 2008-04-15 2009-11-05 Lion Corp Liquid composition for oral cavity
CN102138919A (en) * 2011-01-28 2011-08-03 武汉联合药业有限责任公司 New application of sodium ferrous chlorophyll to promotion of erythropoiesis
CN103027873A (en) * 2011-10-10 2013-04-10 马美琳 Anti-inflammatory hemostatic toothpaste
AU2014205553A1 (en) * 2013-01-08 2015-07-09 Volant Holdings Gmbh Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems
CN117100756A (en) * 2015-01-19 2023-11-24 C·V·萨万基卡尔 Chlorophyllin compositions and uses thereof

Also Published As

Publication number Publication date
WO2016116950A2 (en) 2016-07-28
CN117100756A (en) 2023-11-24
AU2016210540A1 (en) 2017-08-10
EP3247323A2 (en) 2017-11-29
CN107427417A (en) 2017-12-01
WO2016116950A4 (en) 2016-12-01
ES2879996T3 (en) 2021-11-23
US20180325915A1 (en) 2018-11-15
EP3247323B1 (en) 2021-03-03
JP2021006555A (en) 2021-01-21
BR112017015338A2 (en) 2018-01-09
EP3247323A4 (en) 2018-07-11
JP2018502893A (en) 2018-02-01
JP6772151B2 (en) 2020-10-21
AU2016210540B2 (en) 2018-10-11
EA201791319A1 (en) 2018-01-31
WO2016116950A3 (en) 2016-10-13

Similar Documents

Publication Publication Date Title
GB201512030D0 (en) Composition
GB201521507D0 (en) Composition
GB201505527D0 (en) Composition
GB201506827D0 (en) Composition
HK1250339A1 (en) Composition
GB201515640D0 (en) Composition
GB201506830D0 (en) Composition
GB201506829D0 (en) Composition
GB2545773B (en) Composition
GB201522603D0 (en) Composition
GB201506828D0 (en) Composition
GB201518348D0 (en) Composition
GB201514585D0 (en) Composition
GB201511697D0 (en) Composition
GB201509044D0 (en) Composition
GB201505520D0 (en) Composition
GB201504665D0 (en) Composition
GB201504307D0 (en) Composition
SG11201705694VA (en) Chlorophyll composition
GB201522681D0 (en) Composition
GB201519327D0 (en) Composition
GB2537648B (en) Composition
GB201515639D0 (en) Composition
GB201508722D0 (en) Composition
GB201521384D0 (en) Composition